Governance Grifols, S.A.

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME Other stock markets 11:44:08 2026-02-09 am EST			5-day change	1st Jan Change
11.06 ^EUR	+1.75%		+2.50%	+3.36%

Feb. 05	European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading	MT
Jan. 21	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT

Executive Committee: Grifols, S.A.

Manager

Positions heldSince

Nacho Abia

57 year

Chief Executive Officer

2024-03-31

Fernando Sebastian Rodriguez Haro

47 year

Comptroller/Controller/Auditor

2015-12-31

David Bell

72 year

General Counsel

2003-06-30

Nuria Martín Barnés

67 year

Corporate Secretary

2015-05-28

Jörg Schüttrumpf

52 year

Chief Tech/Sci/R&D Officer

2024-08-31

Composition of the Board of Directors: Grifols, S.A.

Director

CommitteesSince

Anne-Catherine Berner

62 year

Compensation Committee	2018-12-31
HR Committee	2018-12-31

Paul Herendeen

70 year

Audit Committee
Finance Committee Chair	2025-05-15
Compensation Committee	2024-12-07
Nominating Committee	2024-12-07

Montserrat Muñoz Abellana

58 year

Audit Committee	2024-07-15
Compensation Committee Chair
Nominating Committee Chair

Victor Grifols Deu

50 year

Compensation Committee
Nominating Committee

Tomás Dagá Gelabert

70 year

Compensation Committee	2010-01-24
Nominating Committee	2010-01-24

Susana González Rodríguez

49 year

Compensation Committee	2022-06-09
Nominating Committee	2022-06-09

Íñigo Sánchez-Asiaín Mardones

61 year

Audit Committee Chair

Pascal Ravery

69 year

Audit Committee

2024-12-07

Raimon Grifols Roura

63 year

Director/Board Member

2015-05-23

Enriqueta Felip Font

61 year

Director/Board Member	2019-05-23
Independent Dir/Board Member	2019-05-23

Albert Coma-Cros

48 year

Director/Board Member

2023-12-18

Nacho Abia

57 year

Director/Board Member

2024-02-25

Víctor Grifols Roura

76 year

Director/Board Member

2022-09-29

Latest Appointments: Grifols, S.A.

Jan. 08	Grifols, S.A. Announces Board Changes, Effective January 1, 2026	CI
25-05-28	Biotest AG Names New CEO	MT
25-05-22	Moody's Lifts Grifols' Ratings on Operating Performance Strength	MT
25-02-25	Grifols' Chairman to Step Down; Successor Named	MT
25-02-25	Grifols to Appoint Anne-Catherine Berner as Chair	MT
25-02-25	Grifols, S.A. Announces Board Changes	CI
25-02-25	Grifols Says Anne Catherine Berner To Succeed Thomas Glanzmann As Non-Executive Chairperson	RE

More news

Former Officers and Directors: Grifols, S.A.

Insider

Positions held

SinceUntil

Maria Teresa Rioné Llano

Public Communications Contact

2017-12-31

2025-02-28

James Costos

Director/Board Member	2020-10-08	2024-09-18
Independent Dir/Board Member	2020-10-08	2024-09-18

Alfredo Arroyo Guerra

Chief Administrative Officer	2010-01-26	2013-05-29
Director of Finance/CFO	2006-12-31	2024-09-15
Director of Research - Fxd Inc	2010-01-26	2010-01-26

Claire Giraut

Director/Board Member	2024-06-13	2024-07-11
Independent Dir/Board Member	2024-06-13	2024-07-11

Carina Szpilka Lázaro

Director/Board Member	2015-05-28	2024-07-11
Independent Dir/Board Member	2015-05-28	2024-07-11

Montserrat Gaja Llamas

Human Resources Officer

2021-06-30

2024-04-30

Marilyn Rosa-Bray

Chief Tech/Sci/R&D Officer	2022-05-31	2023-07-10
General Counsel	2022-05-31	2023-07-10

Xavier Sueiras Gil

Chief Tech/Sci/R&D Officer

2017-12-31

2023-02-28

Steven Mayer

Director/Board Member	2023-02-20	-
Chairman	2022-10-02	2023-02-20
Independent Dir/Board Member	2011-01-24	2023-02-20

Antonio Martínez Martínez

Chief Tech/Sci/R&D Officer

2019-12-31

2022-06-30

Belén Villalonga Morenés

Director/Board Member	2013-05-23	2021-12-31
Independent Dir/Board Member	2013-05-23	2021-12-31

Joseph Schachle

Corporate Officer/Principal

2017-07-31

2021-08-31

Mateo Florencio Borrás Humbert

Human Resources Officer

2010-01-26

2021-05-31

Luís Isasi Fernández de Bobadilla

Director/Board Member	2011-05-24	2020-10-08
Independent Dir/Board Member	2011-05-23	2020-10-08

Edgar Jannotta

Director/Board Member	2010-01-24	2015-06-04
Independent Dir/Board Member	2011-06-01	2015-06-04

Marla E. Salmon

Director/Board Member	2014-05-29	-
Independent Dir/Board Member	2014-05-29	-

Carsten Schroeder

Corporate Officer/Principal

2013-12-31

Brett Ingersoll

Director/Board Member	2011-01-27	-
Independent Dir/Board Member	2011-01-24	-

Lafmin Morgan

Corporate Officer/Principal

2018-06-30

Christian Purslow

Director/Board Member	2010-01-26	-
Independent Dir/Board Member	-	-

Anna Veiga Lluch

Director/Board Member	2008-12-08	-
Independent Dir/Board Member	2008-12-08	-

Eva Bastida Tubau

Chief Tech/Sci/R&D Officer	2006-12-31	-
Corporate Officer/Principal	2012-02-21	-

Thomas Heinrich Glanzmann

Director/Board Member	2006-04-04	2023-02-20
Chief Executive Officer	2023-05-07	2024-03-31
Chairman	2023-02-20	-

José Antonio Grifols Gras

Director/Board Member

2000-01-19

Nuria Pascual Lapeña

Director of Finance/CFO	1995-12-31	-
Investor Relations Contact	1995-12-31	-
Treasurer	-	-

Francisco Javier Jorba Ribes

Corporate Officer/Principal

1994-12-31

Montserrat Lloveras Calvo

Chief Administrative Officer	1990-12-31	-
Comptroller/Controller/Auditor	1990-12-31	-

Juan Ignacio Twose Roura

Director/Board Member	2010-01-24	-
Corporate Officer/Principal	2010-01-28	2013-12-31

Carlos Roura Fernandez

Corporate Officer/Principal

2010-09-27

Vicente Blanquer Torre

Chief Tech/Sci/R&D Officer	1986-12-31	-
General Counsel	2006-12-31	-
Corporate Officer/Principal	1986-12-31	-

Antonio Viñes Páres

Corporate Officer/Principal

2010-09-27

Ramón Riera Roca

Director/Board Member	2000-03-31	-
Corporate Officer/Principal	2010-11-22	2012-02-21
Sales & Marketing	2010-01-26	-

Javier Roura Fernandez

Director of Finance/CFO	2010-01-26	-
Corporate Officer/Principal	2010-11-22	2012-02-21

Christopher Hanna

Director/Board Member

Josep Antoni Grifols Roig

Founder

1940-11-17

Age distribution of managers

Parity Men Women

Male	14
Female	4

Of which Executive Committee

Male	4
Female	1

Of which Directors

Male	10
Female	3

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (85.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (3%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (2.9%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.9%), European Union (15.5%), the United States and Canada (56.7%) and other (21.9%).

Employees

23,800

Sector

Pharmaceuticals

Calendar

Feb. 25 - Q4 2025 Earnings Release (Projected)

More about the company